Selective enhancement of the type 1 cytokine response by expression of a canine interleukin (IL)-12 fused heterodimeric DNA. (Q40335039)

19 September 2017

title

Selective enhancement of the type 1 cytokine response by expression of a canine interleukin (IL)-12 fused heterodimeric DNA. (English)

1 reference

19 September 2017

Omar A Saldarriaga

1

1 reference

19 September 2017

Luis E Perez

series ordinal

2

1 reference

19 September 2017

Bruno L Travi

series ordinal

3

1 reference

19 September 2017

Peter C Melby

series ordinal

4

1 reference

19 September 2017

publication date

28 December 2005

1 reference

Veterinary Immunology and Immunopathology

19 September 2017

published in

1 reference

19 September 2017

volume

110

1 reference

19 September 2017

issue

3-4

1 reference

19 September 2017

page(s)

377-388

1 reference

The adjuvant effect of interleukin-12 in a vaccine against Leishmania major.

19 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016/J.VETIMM.2005.11.003

Basic local alignment search tool

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VETIMM.2005.11.003

Detection, cDNA cloning and sequencing of canine interleukin 12.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VETIMM.2005.11.003

Interleukin-12: a bridge between innate resistance and adaptive immunity with a role in infection and acquired immunodeficiency

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VETIMM.2005.11.003

Enhanced hematopoietic activity of a human granulocyte/macrophage colony-stimulating factor-interleukin 3 fusion protein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VETIMM.2005.11.003

Production of natural killer cell stimulatory factor (interleukin 12) by peripheral blood mononuclear cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VETIMM.2005.11.003

Recombinant single-chain canine interleukin 12 induces interferon gamma mRNA expression in peripheral blood mononuclear cells of dogs with visceral leishmaniasis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VETIMM.2005.11.003

Mouse interleukin-12 (IL-12) p40 homodimer: a potent IL-12 antagonist

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VETIMM.2005.11.003

Coexpression of two distinct genes is required to generate secreted bioactive cytotoxic lymphocyte maturation factor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VETIMM.2005.11.003

Vaccine requirements for sustained cellular immunity to an intracellular parasitic infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VETIMM.2005.11.003

Vaccination with DNA Encoding the Immunodominant LACK Parasite Antigen Confers Protective Immunity to Mice Infected with Leishmania major

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VETIMM.2005.11.003

At least six nucleotides preceding the AUG initiator codon enhance translation in mammalian cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VETIMM.2005.11.003

Quantitative real-time PCR for the measurement of feline cytokine mRNA.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VETIMM.2005.11.003

Bioactive murine and human interleukin-12 fusion proteins which retain antitumor activity in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VETIMM.2005.11.003

The interleukin 12 p40 gene promoter is primed by interferon gamma in monocytic cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VETIMM.2005.11.003

Natural killer cell stimulatory factor (interleukin 12 [IL-12]) induces T helper type 1 (Th1)-specific immune responses and inhibits the development of IL-4-producing Th cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VETIMM.2005.11.003

The interleukin-12 subunit p40 specifically inhibits effects of the interleukin-12 heterodimer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VETIMM.2005.11.003

Genetically resistant mice lacking interleukin-12 are susceptible to infection with Leishmania major and mount a polarized Th2 cell response.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VETIMM.2005.11.003

Leishmania donovani p36(LACK) DNA vaccine is highly immunogenic but not protective against experimental visceral leishmaniasis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VETIMM.2005.11.003

Development of improved vectors for DNA-based immunization and other gene therapy applications

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VETIMM.2005.11.003

Cloning and Expression of the cDNA for Canine Interleukin-12

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VETIMM.2005.11.003

IL-12 is required to maintain a Th1 response during Leishmania major infection.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VETIMM.2005.11.003

Immunostimulatory effects of human recombinant interleukin-12 on peripheral blood mononuclear cells from normal dogs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VETIMM.2005.11.003

Role of IL12 in induction of cell-mediated immunity to Toxoplasma gondii.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VETIMM.2005.11.003

STAT-4 mediated IL-12 signaling pathway is critical for the development of protective immunity in cutaneous leishmaniasis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VETIMM.2005.11.003

IL-12 inhibition of endothelial cell functions and angiogenesis depends on lymphocyte-endothelial cell cross-talk

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VETIMM.2005.11.003

TLR9 pathway is involved in adjuvant effects of plasmid DNA-based vaccines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VETIMM.2005.11.003

Regional Differences in the Cellular Immune Response to Experimental Cutaneous or Visceral Infection withLeishmania donovani

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VETIMM.2005.11.003

10.1016/J.VETIMM.2005.11.003

7 January 2021

Identifiers

DOI

1 reference

19 September 2017

1 reference